Dissecting the role and therapeutic potential of CCNB1IP1 in MYCN‐driven carcinogenesis will enable a better understanding and provide a rational explanation for its use as a new therapeutic strategy and target for NB (Figure 10). The gene discussed is CCNB1IP1; the disease is neuroblastoma.